Medications
Ozempic, Wegovy, Mounjaro, Zepbound, Compounded Semaglutide
Monthly Cost
$99-$279/mo
Speed to Start
Moderate
Est. 2008
About Noom
Noom built its reputation on a psychology-based approach to weight management long before GLP-1 medications entered the mainstream. Founded in 2008, the platform has helped millions of users develop healthier relationships with food through cognitive behavioral techniques, habit tracking, and personalized coaching. Their GLP-1 program, Noom Med, extends that behavioral foundation with clinical weight loss medication.
The medication offerings include both brand-name options (Ozempic, Wegovy, Mounjaro, Zepbound) and compounded semaglutide for patients seeking a more affordable alternative. An insurance concierge service helps patients navigate coverage, similar to Ro’s model. Monthly pricing ranges from $99 to $279 depending on the plan and medication.
What makes Noom Med unique is the integration of their proven behavioral platform with medical treatment. Patients don’t just get a prescription — they get food tracking, psychology-based coaching, and dietitian access wrapped around the medication. The research on GLP-1 outcomes consistently shows that behavioral support improves long-term results, and Noom has more depth in this area than virtually any competitor.
The numbers speak for themselves: a 4.5 Trustpilot rating across an extraordinary 66,000+ reviews combined with an A+ BBB rating. This level of sustained positive feedback at massive scale is a strong indicator of consistent delivery. Few health platforms of any kind achieve this combination.
The moderate onboarding speed and lack of included lab testing are minor drawbacks in an otherwise comprehensive offering. Noom’s psychology-first philosophy means they’re not just prescribing medication — they’re building the behavioral foundation that helps patients keep the weight off even after they stop the medication.
At a Glance
Medications Offered
Ozempic, Wegovy, Mounjaro, Zepbound, Compounded Semaglutide
Both
Cost & Insurance
- Monthly: $99-$279/mo
- 6-month estimate: $594-$1,674
- Insurance: Insurance Concierge
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: Yes
- Verified Pharmacy: Partner pharmacies not publicly disclosed
- BBB Rating: A+
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Moderate
- Spanish-speaking providers: Not available
Start your GLP-1 weight loss journey with Noom today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the Noom Med Intake Looks Like
We walked through Noom Med’s full GLP-1 intake ourselves — from the opening goal screen to the final 4-week supply checkout. It’s the longest and most comprehensive intake we’ve completed to date.
/ 10
Top-tier. Dedicated eating-disorder screen, FDA black-box family history, an eight-symptom GI baseline, Muscle Defense / sarcopenia awareness, and a uniquely thoughtful “would mild nausea stop you?” tolerance question.
/ 10
Moderate. The length is the friction. There’s no ID upload, no OTP, and the UX stays engaging thanks to interspersed educational and motivational screens. The email capture is gated mid-flow before the eligibility reveal.
The 10 Stages
Clinical Safety Screens Performed
One of the most clinically thoughtful individual questions we’ve encountered: Noom directly asks “Would mild nausea make it more likely you’d stop taking a medication?” with Yes / No / Not sure options, then uses that answer to shape a personalized “low and slow” titration plan. GLP-1 adherence problems are almost always driven by early GI side effects, and directly asking about tolerance is a cleaner way to manage that risk than hoping patients push through on their own. Few other intakes we’ve completed acknowledge this dimension at all.
Two dimensions that rarely show up in a GLP-1 intake: an eight-symptom GI frequency baseline (heartburn, bloating, constipation, diarrhea, nausea, and general digestive discomfort scored 0 / 1–3 / 4–9 / 10+ days per month) and a Muscle Defense / sarcopenia goal selection acknowledging that one risk of rapid GLP-1 weight loss is muscle mass loss. Asking about these before prescribing lets a clinician titrate and counsel differently than a baseline-less start.
Despite the depth, a few specific items aren’t in the pre-checkout flow: no actual blood-pressure reading collected, no validated PHQ-2 or PHQ-9 depression instrument (stress frequency is asked but is not a validated clinical scale), no explicit substance-use or alcohol screen, no direct suicide or self-harm question, and no explicit pregnancy check. These items could still come up in the live clinician review after the checkout, but they aren’t in the pre-checkout questionnaire itself.
After the 55-screen flow, the checkout reveals Noom Med’s structure: $129 due today for a 4-week starter supply (with a $90 total savings from the GLP1RX50 promo code applied automatically, reducing from $259), then a recurring $249/month starting with your first 12-week refill. The plan is FSA/HSA eligible. The checkout also notes that the account auto-renews and that cancellation is available before the next refill.
Source: GLP-1.Reviews editorial walkthrough on April 13, 2026. We completed every screen of the Noom Med weight-management intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens noom.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.
